Stem cells have the potential for use in regenerative medicine and tissue engineering applications owing to their ability to differentiate into specialized cell types. In stem cell banking, stem cells are collected from umbilical cord blood, including hematopoietic stem cells and mesenchymal stem cells. The collected stem cells are stored in stem cell banks for future use in case of health issues that can be treated using stem cells. Stem cell banking provides an assurance for treatment of over 80 diseases including cancers, blood disorders, and genetic diseases.
The global stem cell banking market is estimated to be valued at US$ 534.81 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The wide scope of therapeutic applications of stem cells is expected to drive the growth of the stem cell banking market during the forecast period. The number of stem cell regenerative therapies and clinical trials is increasing significantly. Currently, stem cells are being used to treat conditions such as blood disorders, cancers, cardiac diseases, and neuromuscular disorders. In the coming years, the potential use of stem cells in therapies for chronic and degenerative diseases is estimated to further propel the market growth. Newer areas of application such as the treatment of type 1 diabetes, Alzheimer's, Parkinson's, and spinal cord injuries have immense potential and is still under research which is estimated to open new avenues for the stem cell banking market in the long run.
Porter’s Analysis
Threat of new entrants: The high capital requirements associated with infrastructure, equipment and skilled workforce pose a barrier for new players. Furthermore, strict regulations and lengthy approval processes by regulatory authorities protect the existing players.
Bargaining power of buyers: The buyers have moderate bargaining power due to the presence of several service providers in the market. However, the high storage and preservation costs give buyers limited options to negotiate on prices.
Bargaining power of suppliers: The suppliers of critical materials like stem cell vials and freezers have low bargaining power due to the specialized nature of supplies and established supply chains of existing players.
Threat of new substitutes: There are currently no cost-effective or medically superior alternatives to stem cell therapies. However, ongoing research for artificial tissues could emerge as a substitute in the long run.
Competitive rivalry: Intense due to the large number of global and regional companies. Players compete based on service quality, innovative offerings, geographic reach and strong brand image.
SWOT Analysis
Strengths: Growing awareness of stem cell therapies, increasing prevalence of chronic diseases, advancement in bio-banking infrastructure.
Weaknesses: High operational costs, ethical concerns regarding stem cell collection, stringent regulations.
Opportunities: Emerging markets with large patient population, expansion into non-medical applications like cosmetics, collaborations for new therapies.
Threats: Slow regulatory approvals, competition from alternative treatments, economic slowdowns affecting investment.
Key Takeaways
The Global Stem Cell Banking Market Size is expected to witness high growth due to the rising incidence of cancer, diabetes and cardiac disorders. The global stem cell banking market is estimated to be valued at US$ 534.81 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030.
The market in Asia Pacific region is projected to grow at the fastest rate owing to high population, increasing healthcare expenditure and government support for stem cell research.
North America currently dominates the market due to availability of advanced healthcare facilities and positive regulatory scenario supporting clinical trials. However, Asia Pacific is emerging as the growth engine on back of economies like China, India and Japan rapidly enhancing their stem cell banking infrastructure.
Key players: Key players operating in the stem cell banking market are Cord Blood Registry, ViaCord, Cryo-Save, StemCyte, Cryo-Cell International and LifeCell.
Get More Insights Here
https://www.trendingwebwire.com/stem-cell-banking-market-size-share-growth-outlook-2023/
Comments
0 comment